Insulin lispro in combination with sulfonylurea therapy significantly reduced 2-h postprandial glucose concentrations compared with sulfonylureas alone , from 18.6 to 14.2 mmol/l ( P < 0.0001 ) , and incremental postprandial glucose area from 617.8 to 472.9 mmol.min.1-1 ( P < 0.0007 ) .
